Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54,331
Closed -$2.62M 328
2026
Q1
$2.62M Buy
54,331
+3,190
+6% +$149K 0.21% 101
2025
Q4
$2.48M Buy
51,141
+10,421
+26% +$517K 0.2% 108
2025
Q3
$1.92M Buy
40,720
+5,648
+16% +$273K 0.16% 125
2025
Q2
$1.69M Buy
+35,072
New +$1.79M 0.15% 132
2024
Q1
Sell
-6,531
Closed -$325K 255
2023
Q4
$325K Sell
6,531
-35,291
-84% -$1.73M 0.05% 210
2023
Q3
$2.24M Buy
41,822
+775
+2% +$41.3K 0.3% 89
2023
Q2
$2.21M Buy
41,047
+793
+2% +$42.7K 0.32% 88
2023
Q1
$2.19M Buy
40,254
+3,185
+9% +$155K 0.35% 81
2022
Q4
$1.8M Buy
37,069
+15,585
+73% +$684K 0.32% 88
2022
Q3
$817K Buy
21,484
+6,418
+43% +$286K 0.2% 130
2022
Q2
$754K Buy
15,066
+2,294
+18% +$122K 0.21% 125
2022
Q1
$656K Buy
12,772
+2,074
+19% +$107K 0.16% 127
2021
Q4
$536K Buy
10,698
+898
+9% +$44.4K 0.14% 141
2021
Q3
$472K Buy
9,800
+767
+8% +$39K 0.15% 133
2021
Q2
$476K Buy
9,033
+251
+3% +$13.1K 0.15% 139
2021
Q1
$434K Buy
8,782
+268
+3% +$12.9K 0.16% 130
2020
Q4
$414K Buy
+8,514
New +$420K 0.17% 124

Other funds holding SNY

CGN Advisors's SNY Position: Q2 2026 in Review

CGN Advisors sold out of Sanofi (SNY) in Q2 2026, closing a stake of 54,331 shares — an estimated $2.62M sold.

CGN Advisors first reported a position in SNY in Q4 2020 and held it in 17 quarters. The position peaked at $2.62M in Q1 2026. 107 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • CGN Advisors reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • CGN Advisors sold 54,331 Sanofi shares in Q2 2026, an estimated $2.62M.
  • CGN Advisors first reported a position in Sanofi in Q4 2020 and held it in 17 quarters.
  • CGN Advisors's Sanofi position peaked at $2.62M in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.